1. Corrigendum to 'Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction'[YPLAC 64C (2018) 61–70]. (September 2018) Authors: Verheecke, M.; Cortès Calabuig, A.; Finalet Ferreiro, J.; Brys, V.; Van Bree, R.; Verbist, G.; Everaert, T.; Leemans, L.; Gziri, M.M.; Boere, I.; Halaska, M.J.; Van Houdt, J.; Amant, F.; Van Calsteren, K. Journal: Placenta Issue: Volume 69(2018) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction. (April 2018) Authors: Verheecke, M.; Cortès Calabuig, A.; Finalet Ferreiro, J.; Brys, V.; Van Bree, R.; Verbist, G.; Everaert, T.; Leemans, L.; Gziri, M.M.; Boere, I.; Halaska, M.J.; Vanhoudt, J.; Amant, F.; Van Calsteren, K. Journal: Placenta Issue: Volume 64(2018) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1677: THROMBOSIS IN PREGNANT CANCER PATIENTS: A SYSTEMATIC REVIEW OF THE LITERATURE. (23rd June 2022) Authors: Bos, S.; Rier, H.; Duvekot, H.; Boere, I.; Kruip, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1341 RECIST 1.1 in cervix cancer radiation and drug trials: Is there a difference in measured outcomes?. (May 2022) Authors: Chopra, S.; Charnalia, M.; Mulani, J.; Popat, P.; Rath, S.; Gurram, L.; Mittal, P.; Boere, I.; Gupta, S.; Nout, R. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗